The lack of inhibition of MMP-2 enzymatic activity by all peptides contrasts the claim by Deshane et al. that MMP-2 is the primary receptor for Ctx on GBM cell surfaces [28]. This evidence concerns the gene CYP27A1 and glioblastoma.